Cost changes are key factor in pharma partnerships

SCORR Marketing and Applied Clinical Trials have released the results of its Partnerships Survey Report, indicating that cost changes are a key factor that negatively impact partnerships.

The report gathered insights on the perceptions of outsourcing partnerships involving pharmaceutical companies, contract research organisations (CROs) and contract manufacturing organisations (CMOs). “In this report, we provide information on the attributes outsourcing partners need and the benefits they provide, whether outsourcing decisions are primarily tactical or strategic, and the number of strategic partnerships that companies have and want,” said Cliff Echols, market intelligence director at SCORR Marketing. “In addition, the report contains information on perceptions of the value offered by various service companies, the effect strategic partnerships have on various companies and how mergers and acquisitions affect partnerships.”

Lisa Henderson, editor in chief at Applied Clinical Trials commented, “Results from the survey indicated that cost changes are the key factor that most negatively impact partnerships among sponsors, CROs and CMOs, followed closely by staffing changes. We also found that small companies want a partner that can provide them additional expertise, but large companies are more interested in increased efficiency.”